Articles tagged with Ampk Signaling
A new study published in Science Advances has shed light on how the body responds to energy demands from exercise, identifying a crucial cell signaling mechanism that could lead to a new treatment for diabetes. The research focuses on Adenosine Monophosphate-Activated Protein Kinase (AMPK), a regulator of energy production, and reveals...
A comprehensive review synthesizes emerging evidence on AMPKα isoforms' dual roles in Alzheimer's disease. The analysis proposes that this complexity may explain why pharmacological approaches have yielded mixed results in treating the disease. Isoform-specific targeting is proposed as a novel therapeutic strategy.
This study investigates SOX9's role in MASH pathogenesis and explores its underlying mechanisms. SOX9 overexpression alleviates hepatic lipid accumulation by activating the AMPK pathway.
Researchers explore Extracellular signal-regulated kinase 5 (Erk5) and its unique structures regulating autophosphorylation and transcription. Erk5 is involved in angiogenesis, neurogenesis, energy metabolism, tumor growth, and metastasis, making it a potential target for cancer treatment.
Researchers discovered a connection between mitochondrial calcium transport and autophagy, a process where cells break down and reuse components. The study found that NCLX protein plays a crucial role in regulating this link, which has implications for understanding energy metabolism and developing disease treatments.
Researchers found that Angelica gigas extract improves vascular function in high-fat diet rats, reversing endothelial dysfunction and increasing NO bioavailability. The extract regulates IRE1α sulfonation and RIDD signaling, promoting NO production via the SIRT1-eNOS axis.
Researchers found that 1,5-AF activated AMPK, leading to upregulation of the PGC-1α/BDNF pathway and alleviating aging-related decline in motor cognitive function. The study suggests that 1,5-AF can induce endogenous neurovascular protection, potentially preventing aging-associated brain diseases.
Researchers discovered a new role for extracellular signal-regulated kinase (ERK) in a pathway activated by interferon-gamma that leads to cancer cell death. Hyperactivation of ERK causes stress in cells, triggering cell death through specific proteins DR5 and NOXA.
Research identifies key molecular signatures and pathways contributing to skeletal muscle strength loss in females with estrogen deficiency. The study found parallel patterns of inhibition and activation across various signaling pathways, including AMPK and calcium signaling.
Researchers uncover the critical link between cellular energy levels and mitochondrial damage through protein FNIP1. The study reveals that FNIP1 enables communication between AMPK and TFEB, instructing genes to remove damaged mitochondria and create new ones.
A novel small molecule, MK-8722, has been shown to trigger improved muscle health in mice with muscular dystrophy by activating AMPK. This finding highlights the potential of this class of AMPK activators as a cost-effective and efficacious method for DMD treatment.
Researchers found that suppressing AMPKα1 but not AMPKα2 isoforms improved aging-related impairments in mice. The study revealed novel insights into the roles of AMPK signaling pathway in cognitive aging.
A study found that time-restricted feeding improves muscle performance in obese fruit flies by upregulating genes related to glycine production and utilization. This approach may provide a natural alternative therapy for managing obesity-related pathologies.
Researchers at RIKEN have discovered how marsupials' hearts can regenerate for several weeks after birth, allowing for potential treatment of human heart disease. They found that inhibiting a protein called AMPK extended the period of regeneration in both mice and opossums, with minimal scarring.
A team of researchers at NYU Abu Dhabi has discovered a novel structural modification in AMP-activated protein kinase that could pave the way for more effective cancer treatments. The study found that a specific enzyme cleaves and traps the protein in the cell nucleus, rendering it resistant to chemotherapy and radiotherapy.
A Swiss-French team has identified a mechanism that could lead to the development of new therapies for acute myeloid leukaemia, a particularly dangerous form of cancer. The selective activation of AMPK triggers apoptosis in tumour cells by initiating the cell's stress response.
Researchers at Kobe University discover that adding Vitamin B2 to stressed cells increases mitochondrial energy production and prevents cellular senescence. This finding has potential implications for preventing age-related disorders and extending healthy lifespans.
A study led by LSU Health found how late-onset retinal degeneration develops and identified a surprising potential therapeutic, metformin. The research suggests that an enzyme called AMPK activates the protein CTRP5 to regulate fatty acid metabolism and energy stability.
Researchers at Salk Institute discover that metformin's anti-inflammatory effects require communication between AMPK and mTORC1. The study sheds light on the molecular mechanisms of metformin's action and reveals its potential as a treatment for inflammatory diseases, including liver inflammation.
Scientists at Salk Institute discovered that metformin activates multiple biochemical switches, including Protein Kinase D and MAPKAPK2, which may explain its health-span-extending effects. The study identified new targets and cellular processes regulated by AMPK, shedding light on the therapeutic benefits of metformin.
Researchers have developed a new model to study the health effects of metabolic protein AMPK, revealing its potential as a treatment for nonalcoholic fatty liver disease and other diseases. By activating AMPK in mice with fatty liver disease, scientists found that it lowered liver fat and protected against weight gain and obesity.
Undernutrition delays puberty onset by enhancing AMPK levels in the hypothalamus of female rodents. Overexpressing active AMPK also delays puberty, implying its role in regulating female puberty via kisspeptin signaling.
Researchers at San Francisco State University have discovered a breakthrough technique for testing AMPK protein levels in human muscle cells. This innovative approach allows for precise analysis of individual muscle fibers, enabling better understanding of how the body regulates blood sugar levels.
Researchers have identified potential therapies for myotonic dystrophy type I (MD1) by targeting AMPK and mTORC1 pathways, which are disrupted in MD1 muscle tissue. Treatment with drugs that activate these pathways improves muscle function and reduces abnormal gene splicing.
Researchers have identified a new biochemical pathway that can be controlled using metformin and salicylate, two widely used medicines. This approach could lead to the development of new therapies for inflammatory disorders, including those caused by faulty Janus kinase proteins.
Researchers found that metformin reversed early cellular aging, causing increased sestrin 2 levels and AMPK activity, which led to full-term births in mice. The study provides new clues into the molecular pathway of preterm birth and suggests a potential safer alternative to rapamycin for preventing premature birth.
Researchers discover that AMPK, a protein activated during fasting, regulates 'hunger' neurons involved in feeding behavior, leading to increased food intake and body weight. Blocking AMPK activity reduces hunger and AgRP neuron firing, even after fasting.
Researchers at the Salk Institute found that a protein complex called AMPK plays a critical role in monitoring and managing cells' energy processes during development. The discovery sheds new light on cancer and diabetes pathways, offering potential insights into stem cell therapies and cancer treatments.
AMPK activity levels vary across cellular compartments, affecting different sets of proteins. In unstressed cells, the nucleus, cytoplasm, and cell membrane had low activity, while the Golgi apparatus and endoplasmic reticulum showed high activity.
Researchers have identified a new biomarker that can help identify patients who are more likely to respond to certain chemotherapies. MAGE-A3/6 genes contribute to tumor growth by inhibiting AMPK, a protein that controls cellular energy levels and suppresses cancerous tumors.
A new study found that hyperactivation of AMP-activated protein kinase (AMPK) amplifies Huntington's disease by promoting neuronal death and reducing cell survival. The findings suggest that AMPK could be a therapeutic target for the treatment of HD.
Scientists found that AMPK, a metabolic master switch, triggers autophagy by activating the enzyme ATG1. This process helps cells recycle debris and survive starvation better, which is significant for aging-related diseases like type II diabetes and Parkinson's disease.
A new study reveals that the protein T-cadherin is necessary for adiponectin's cardioprotective functions. Adiponectin activates AMPK, which regulates energy usage in the cell. The absence of T-cadherin leads to impaired AMPK activity and increased cardiac damage.
Researchers discover that mitochondrial diseases increase susceptibility to bacterial infection, particularly with pneumonia-causing bacteria like Legionella. The stress-signal associated with metabolic abnormalities encourages the growth and reproduction of these bacteria.
A study by the University of South Florida Health Sciences Center found that resveratrol reduces fat production and increases breakdown in the liver of mice fed alcohol. This prevents accumulation of fat and suggests resveratrol as a promising agent for preventing or treating human alcoholic fatty liver disease.
Scientists discovered that when food supplies dwindle, mammals activate the AMPK signaling pathway to conserve energy. The study reveals a link between cancer and diabetes, suggesting that type 2 diabetes drug metformin may also antagonize tumor growth.
Aging animals show reduced AMPK activity in skeletal muscle, leading to decreased mitochondrial function and increased intracellular fat content. This decline contributes to insulin resistance and type 2 diabetes.